BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24376133)

  • 21. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
    van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
    Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
    Hoentjen F; Hanauer SB; de Boer NK; Rubin DT
    Dig Dis Sci; 2012 Jan; 57(1):250-3. PubMed ID: 22147254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
    Nygaard U; Toft N; Schmiegelow K
    Clin Pharmacol Ther; 2004 Apr; 75(4):274-81. PubMed ID: 15060506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
    Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
    Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.
    Vang SI; Schmiegelow K; Frandsen T; Rosthøj S; Nersting J
    Cancer Chemother Pharmacol; 2015 May; 75(5):1089-93. PubMed ID: 25788208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trial.
    Hanff LM; Mathot RA; Smeets O; Postma DJ; Ramnarain S; Vermes A; Pieters R; Zwaan CM
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):653-62. PubMed ID: 24800919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Forestier E; Kristinsson J; Söderhäll S; Vettenranta K; Weinshilboum R; Wesenberg F;
    Leukemia; 2009 Mar; 23(3):557-64. PubMed ID: 18987654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease.
    Kopylov U; Amre D; Theoret Y; Deslandres C; Seidman EG
    J Pediatr Gastroenterol Nutr; 2014 Oct; 59(4):511-5. PubMed ID: 24918978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose.
    Welch J; Lennard L; Morton GC; Lilleyman JS
    Ther Drug Monit; 1997 Aug; 19(4):382-5. PubMed ID: 9263376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
    Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S
    J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia.
    Halonen P; Mattila J; Mäkipernaa A; Ruuska T; Schmiegelow K
    Pediatr Blood Cancer; 2006 Jun; 46(7):762-6. PubMed ID: 16395677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma.
    Hedeland RL; Hvidt K; Nersting J; Rosthøj S; Dalhoff K; Lausen B; Schmiegelow K
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):485-91. PubMed ID: 19956952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series.
    Seinen ML; de Boer NK; Smid K; van Asseldonk DP; Bouma G; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1085-90. PubMed ID: 22132961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases.
    Chapdelaine A; Mansour AM; Troyanov Y; Williamson DR; Doré M
    Clin Rheumatol; 2017 Jun; 36(6):1341-1348. PubMed ID: 28130685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.
    Adam de Beaumais T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2011 Apr; 71(4):575-84. PubMed ID: 21395650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
    Barone T; Dandekar S; McKeone D; Mulieri K
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies.
    Lennard L; Lewis IJ; Michelagnoli M; Lilleyman JS
    Med Pediatr Oncol; 1997 Oct; 29(4):252-5. PubMed ID: 9251729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopurinol: a useful adjunct to thiopurine therapy for pediatric ulcerative colitis in the biologic era.
    Ihekweazu FD; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):22-4. PubMed ID: 24590210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allopurinol to Prevent Mercaptopurine Adverse Effects in Children and Young Adults With Acute Lymphoblastic Leukemia.
    Kamojjala R; Bostrom B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):95-100. PubMed ID: 33750748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.
    Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM
    Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.